Answer
Nov 14, 2024 - 01:38 PM
Rexulti (brexpiprazole) is an atypical antipsychotic medication that primarily affects the brain's neurotransmitter systems, particularly dopamine and serotonin. It acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and as an antagonist at serotonin 5-HT2A receptors. This modulation helps balance these neurotransmitters, which can alleviate symptoms of conditions like schizophrenia and major depressive disorder.
